Andrea Impellizzeri

Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

Pasquale Paolisso, Luca Bergamaschi, Gaetano Santulli et al. · Cardiovascular Diabetology · 2022 · 208 citations · Full text

Medicine, Cardiology, Pharmacology +17

Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry

Pasquale Paolisso, Luca Bergamaschi, Felice Gragnano et al. · Pharmacological Research · 2022 · 146 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

Arturo Cesaro, Felice Gragnano, Pasquale Paolisso et al. · Frontiers in Cardiovascular Medicine · 2022 · 88 citations · Full text

Medicine, Cardiology, Pharmacology +17

Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry

Pasquale Paolisso, Luca Bergamaschi, Arturo Cesaro et al. · Diabetes Research and Clinical Practice · 2023 · 79 citations · Full text

Medicine, Cardiology, Pharmacology +17

Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction

Matteo Armillotta, Luca Bergamaschi, Pasquale Paolisso et al. · Circulation · 2025 · 54 citations · Full text

Medicine, Cardiology, Internal Medicine +17